AI Science Tracker
EN

Nanchang University

2 discoveries from 2022 to 2025

Discoveries

Investigating the metabolic reprogramming mechanisms in diabetic nephropathy: a comprehensive analysis using bioinformatics and machine learning.

Source check: Source checked. Not independent scientific confirmation.

Finding: Four machine-learning algorithms combined with WGCNA and protein-interaction analysis identified six metabolic-reprogramming genes associated with diabetic nephropathy across three GEO transcriptome datasets.

Technology: Four-based analysis

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Four-based analysis
Test and result
The analysis identified 256 metabolic DEGs and six key genes; ROC analysis supported diagnostic value, and qRT-PCR in human samples confirmed CXCR2, NAMPT and CUEDC2 expression patterns. Dataset integration and observational validation do not establish causality.
Limitation / still unknown
The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12426288/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

A Methylation Diagnostic Model Based on Random Forests and Neural Networks for Asthma Identification

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary full text's Methods and Results support the assigned case-specific AI-enabled result: The methylation models distinguish asthma diagnoses and are validated on two external datasets.

Technology: Random Forest and neural-network methylation models

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Uses DNA-methylation features to distinguish asthma cases from controls and evaluates the models on two external datasets.
Test and result
The full text describes its data/cohort, comparison and evaluation appropriate to the represented result; the claim is limited to this study.
Limitation / still unknown
The reported evaluation does not establish prospective benefit or performance beyond the studied setting.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9534672/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.